Vimarsana
Biggest News Aggregation in the World

Page 7 - Devin Mclaughlin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Devin Mclaughlin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Devin Mclaughlin Today - Breaking & Trending Today

Cops donate body armor to Ukraine war effort - Vimarsana News

Cops donate body armor to Ukraine war effort

Last week, Lamoille County sheriff Roger Marcoux found himself repaying a favor from three decades ago, donating surplus body armor to help in a conflict far from Vermont’s mountains.

Source: vtcng.com
Social risk factors 'heavily influence' racial disparities in cancer surgical care - Vimarsana News

Social risk factors 'heavily influence' racial disparities in cancer surgical care

Black Medicare beneficiaries who underwent elective cancer surgery had higher rates of mortality than their white counterparts, irrespective of neighborhood deprivation or dual eligibility status, according to study results.The findings, presented at Society of Surgical Oncology International 2022 Conference on Surgical Cancer Care, also showed a more pronounced effect of race among those with

Source: healio.com
Immune cell parameters linked to therapeutic efficacy in advanced renal cell carcinoma - Vimarsana News

Immune cell parameters linked to therapeutic efficacy in advanced renal cell carcinoma

SAN FRANCISCO — Certain immune cell-related parameters appeared associated with efficacy of immune checkpoint inhibitors among patients with advanced or metastatic clear cell renal cell carcinoma, according to study results.“These immune cell parameters may represent novel predictive biomarkers for the response to nivolumab and/or nivolumab plus ipilimumab therapy in clear cell [renal

Source: healio.com
Some men with prostate cancer may benefit from continued enzalutamide after progression - Vimarsana News

Some men with prostate cancer may benefit from continued enzalutamide after progression

SAN FRANCISCO — Continued enzalutamide, after progression on the drug, in combination with docetaxel significantly extended PFS compared with placebo and docetaxel among men with metastatic castration-resistant prostate cancer, study results showed.Enzalutamide (Xtandi; Astellas, Pfizer), an androgen receptor antagonist, plus docetaxel also demonstrated an acceptable safety profile in the

Source: healio.com
Olaparib regimen benefits men with metastatic castration-resistant prostate cancer - Vimarsana News

Olaparib regimen benefits men with metastatic castration-resistant prostate cancer

SAN FRANCISCO  — The addition of olaparib to abiraterone acetate significantly extended radiographic PFS as first-line treatment for metastatic castration-resistant prostate cancer, according to an interim analysis of the randomized phase 3 PROpel study. The findings, presented at ASCO Genitourinary Cancers Symposium, showed men experienced the benefit regardless of homologous

Source: healio.com